Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10535054 | 0.89 | SMN1; SMN2 (0.45) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL7706526 | 0.88 | SMN1; SMN2 (0.40) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL28515317 | 0.86 | SMN1; SMN2 (0.40) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL6925027 | 0.85 | SMN1; SMN2 (0.41) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL13858310 | 0.85 | SMN1; SMN2 (0.41) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL6925032 | 0.85 | SMN1; SMN2 (0.41) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL6925024 | 0.85 | SMN1; SMN2 (0.41) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL5524988 | 0.84 | SMN1; SMN2 (0.39) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL23130401 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A | |
| SCHEMBL24229968 | 0.82 | ALDH1A1 (0.46) | SMN1; SMN2L3MBTL1ALDH1A1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399902-B1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS | CHINA PETROLEUM & CHEMICAL (CN) | 2014-11-26 | — | — | EP | claimed |
| US-8669392-B2 | Process for preparing 2,3-di-non-straight-alkyl-2-cyanosuccinic acid diesters | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2014-03-11 | — | — | US | claimed |
| US-20120046490-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2012-02-23 | — | — | US | claimed |
| EP-2399902-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANO SUCCINIC ACID DIESTERS | China Petroleum & Chemical Corporation (CN) | 2011-12-28 | — | — | EP | claimed |
| EP-0938509-B1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE SPA (IT) | 2002-11-20 | — | — | EP | claimed |
| US-6143684-A | FOR STEREOSPECIFIC POLYMERIZATION OF OLEFINS SUCH AS PROPYLENE | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 2000-11-07 | — | — | US | claimed |
| EP-0938509-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montell Technology Company bv (NL) | 1999-09-01 | — | — | EP | claimed |
| WO-1999011677-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 1999-03-11 | — | — | WO | claimed |
| EP-4688778-A1 | 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | Biogen MA Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4524129-A1 | METHOD FOR PREPARING 2-SUBSTITUTED ARYL ACETONITRILE COMPOUND AND USE THEREOF | Maxunitech Inc. (CN) | 2025-03-19 | — | — | EP | disclosed |
| US-20250059132-A1 | METHOD FOR PREPARING 2-SUBSTITUTED ARYLACETONITRILE COMPOUND AND APPLICATION THEREOF | MAXUNITECH INC (CN) | 2025-02-20 | — | — | US | disclosed |
| WO-2024211696-A1 | 1H-PYRROLO[2,3-B]PYRIDIN-4-YL]-2-OXOPYRROLIDINE-3-CARBONITRILE DERIVATIVES AS TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | BIOGEN MA INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| CN-118330121-A | Method for determining characteristic aroma components of rambutan seed oil by combining GC-MS and GC-IMS | 海南大学 | 2024-07-12 | — | — | CN | disclosed |
| CN-117069614-A | Preparation method and application of 2-substituted aryl acetonitrile compound | 合力科技股份有限公司 | 2023-11-17 | — | — | CN | disclosed |
| US-6153591-A | PROTECTING NERVOUS SYSTEM FOLLOWING FOCAL ISCHEMIA AND GLOBAL ISCHEMIA; ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, PRION DISEASES, PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, AMYOTROPHIC LATERAL SCLEROSIS, ALOPACIA, RHEUMATOID ARTHRITIS | CYTOVIA, INC. (US) | 2000-11-28 | — | — | US | disclosed |
| US-6143684-A | FOR STEREOSPECIFIC POLYMERIZATION OF OLEFINS SUCH AS PROPYLENE | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 2000-11-07 | — | — | US | disclosed |
| WO-1999047154-A1 | DIPEPTIDE CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA, INC. (US) | 1999-09-23 | — | — | WO | disclosed |
| EP-0938509-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Montell Technology Company bv (NL) | 1999-09-01 | — | — | EP | disclosed |
| WO-1999011677-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | MONTELL TECHNOLOGY COMPANY B.V. (NL) | 1999-03-11 | — | — | WO | disclosed |
| US-4141915-A | REACTING AN UNSATURATED NITRILE, AN ALCOHOL, AND CARBON MONOXIDE | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046490-A1 | PROCESS FOR PREPARING 2,3-DI-NON-STRAIGHT-ALKYL-2-CYANOSUCCINIC ACID DIESTERS | ACMSD, ADSL, CNDP2 | SMN1; SMN2 490/4885L3MBTL1 4547/4885ALDH1A1 1240/4885 |
| US-20250059132-A1 | METHOD FOR PREPARING 2-SUBSTITUTED ARYLACETONITRILE COMPOUND AND APPLICATION THEREOF | CYP1B1, CYP1A2, CYP2C9 | SMN1; SMN2 2364/4885L3MBTL1 4731/4885ALDH1A1 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.